Results from expert surveys provide snapshots of our understanding of DME and shed light on where the 0.19-mg FAc implant stands in the current standard of care.
Mark R. Barakat, MD
Advertisement
Articles by Mark R. Barakat, MD
Advertisement
Latest Updated Articles
Precision medicine in diabetic macular edema: Expert consensus on the efficacy and safety of the 0.19-mg fluocinolone acetonide implantPublished: September 22nd 2023 | Updated:
Advertisement
Advertisement
Trending on Modern Retina
1
Macular laser picks up speed: The technology accelerating retinal therapies
2
STAAR Surgical terminates proposed acquisition by Alcon
3
Evaluating Safety and Clinical Confidence between Aflibercept 8 mg and 2 mg in Retinal Vascular Diseases
4
Treating MacTel: First identify patient candidates and appropriate eye selection
5